% | $
Quotes you view appear here for quick access.

ImmunoGen, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • biobottom biobottom Feb 7, 2011 7:46 PM Flag

    Ned Davis Research Upgrade to Neutral

    Useless. Does not apply. But what still concerns is that very low royalty percentage, estimated at 4%. Is this indicative of lame negotiating by IMGN? I still don't understand why it was so low, for something with so much value for Roche.

2.045-0.035(-1.68%)11:29 AMEDT